Table 2. Relation between EV-markers and heart failure, corrected for confounders (age, gender, hypertension, diabetes, chronic renal impairment, anemia, MI, Cerebrovascular accident (CVA), beta-blocker, ACE inhibitor, Statins, Aspirin, and diuretics).
p-value | Odds ratio | 95% C.I.for EXP(B) | ||
---|---|---|---|---|
Lower | Upper | |||
Cystatin C | ||||
TEX | 0.97 | 1.01 | 0.70 | 1.44 |
LDL | 0.27 | 1.18 | 0.88 | 1.58 |
HDL | 0.28 | 1.20 | 0.86 | 1.69 |
CD14 | ||||
TEX | 0.94 | 0.99 | 0.73 | 1.34 |
LDL | 0.75 | 0.95 | 0.72 | 1.27 |
HDL | 0.01 | 1.53 | 1.09 | 2.16 |
Serpin F2 | ||||
TEX | 0.02 | 0.71 | 0.54 | 0.95 |
LDL | 0.01 | 0.65 | 0.47 | 0.88 |
HDL | 0.78 | 0.96 | 0.73 | 1.27 |
Serpin G1 | ||||
TEX | 0.00 | 1.55 | 1.15 | 2.08 |
LDL | 0.24 | 0.81 | 0.57 | 1.15 |
HDL | 0.83 | 0.97 | 0.73 | 1.28 |
Reference groups were the patients without heart failure. Statistically significant differences are shown in bold.